Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Asthma | 14 | 2021 | 4383 | 1.18 | Why? |
| Matrix Metalloproteinase 12 | 1 | 2021 | 17 | 0.89 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2021 | 3832 | 0.77 | Why? |
| Precision Medicine | 5 | 2020 | 1477 | 0.67 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.58 | Why? |
| Medication Therapy Management | 1 | 2018 | 312 | 0.57 | Why? |
| Molecular Targeted Therapy | 3 | 2020 | 1579 | 0.53 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 595 | 0.52 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.52 | Why? |
| Saline Solution, Hypertonic | 1 | 2010 | 81 | 0.39 | Why? |
| Hypersensitivity | 4 | 2021 | 1137 | 0.39 | Why? |
| Biological Products | 2 | 2019 | 2331 | 0.33 | Why? |
| Anti-Asthmatic Agents | 3 | 2021 | 427 | 0.29 | Why? |
| Nitric Oxide | 1 | 2010 | 769 | 0.25 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.24 | Why? |
| Enoximone | 1 | 2021 | 13 | 0.23 | Why? |
| Sputum | 1 | 2010 | 1720 | 0.22 | Why? |
| Matrix Metalloproteinase Inhibitors | 1 | 2021 | 45 | 0.22 | Why? |
| Phosphodiesterase 3 Inhibitors | 1 | 2021 | 25 | 0.22 | Why? |
| Bronchial Provocation Tests | 1 | 2018 | 20 | 0.20 | Why? |
| Receptors, Interleukin-13 | 1 | 2018 | 4 | 0.19 | Why? |
| Receptors, Interleukin-4 | 1 | 2018 | 11 | 0.19 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.18 | Why? |
| Uteroglobin | 1 | 2017 | 10 | 0.18 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.17 | Why? |
| Respiratory System Agents | 1 | 2018 | 63 | 0.17 | Why? |
| Phenotype | 4 | 2019 | 4037 | 0.16 | Why? |
| Administration, Inhalation | 2 | 2018 | 1647 | 0.14 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.14 | Why? |
| Toll-Like Receptor 3 | 1 | 2017 | 391 | 0.14 | Why? |
| Leukotriene Antagonists | 2 | 2018 | 37 | 0.13 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Picornaviridae Infections | 1 | 2017 | 544 | 0.12 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.11 | Why? |
| Biomarkers | 6 | 2021 | 23361 | 0.11 | Why? |
| Rhinovirus | 1 | 2017 | 979 | 0.11 | Why? |
| Allergens | 1 | 2017 | 728 | 0.11 | Why? |
| Respiratory Tract Diseases | 1 | 2019 | 1061 | 0.10 | Why? |
| Congresses as Topic | 1 | 2019 | 1347 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Ketotifen | 1 | 2007 | 9 | 0.09 | Why? |
| Xanthines | 1 | 2007 | 27 | 0.08 | Why? |
| Forced Expiratory Volume | 1 | 2010 | 632 | 0.08 | Why? |
| Adrenergic beta-Agonists | 1 | 2007 | 93 | 0.08 | Why? |
| Cholinergic Antagonists | 1 | 2007 | 56 | 0.08 | Why? |
| Histamine H1 Antagonists | 1 | 2007 | 79 | 0.08 | Why? |
| Breath Tests | 1 | 2010 | 338 | 0.08 | Why? |
| Exhalation | 1 | 2010 | 441 | 0.08 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.08 | Why? |
| History, 19th Century | 1 | 2007 | 384 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Bronchodilator Agents | 1 | 2007 | 444 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| History, 20th Century | 1 | 2007 | 1282 | 0.05 | Why? |
| Methacholine Chloride | 1 | 2018 | 14 | 0.05 | Why? |
| Mannitol | 1 | 2018 | 34 | 0.05 | Why? |
| Allergists | 1 | 2021 | 266 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Information Technology | 1 | 2021 | 278 | 0.04 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Respiratory Hypersensitivity | 1 | 2018 | 103 | 0.04 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 142 | 0.04 | Why? |
| Adrenal Cortex Hormones | 2 | 2018 | 6537 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.03 | Why? |
| Adenosine | 1 | 2018 | 509 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| Societies, Medical | 2 | 2019 | 6907 | 0.03 | Why? |
| Exosomes | 1 | 2018 | 567 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2018 | 693 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Advisory Committees | 1 | 2018 | 1418 | 0.03 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.03 | Why? |
| Bronchi | 1 | 2017 | 1048 | 0.03 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.02 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Physician-Patient Relations | 1 | 2018 | 1266 | 0.02 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Adult | 4 | 2019 | 244371 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Anxiety | 1 | 2019 | 17311 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
Diamant's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(150)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_